期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
毛条细度的综合评定——综合细度
1
作者 马步虎 吕进 +2 位作者 马仁富 张宏伟 周英波 《纺织学报》 EI CAS CSCD 北大核心 1996年第4期37-39,共3页
提出了毛条细度的综合评定指标——综合细度。对估价毛条细度适用于纺纱和织造是个很好的指南,可为毛条的加工者和购买者从综合细度的使用中获得益处。
关键词 毛条 细度 综合细度 评定
下载PDF
Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms:Experience with Rifaximin 被引量:19
2
作者 Sergio Peralta Claudia Cottone +2 位作者 Tiziana Doveri Piero Luigi Almasio Antonio Craxi 《World Journal of Gastroenterology》 SCIE CAS CSCD 2009年第21期2628-2631,共4页
AIM: TO estimate the prevalence of small intestinal bacterial overgrowth (SIBO) in our geographical area (Western Sicily, Italy) by means of an observational study, and to gather information on the use of locally... AIM: TO estimate the prevalence of small intestinal bacterial overgrowth (SIBO) in our geographical area (Western Sicily, Italy) by means of an observational study, and to gather information on the use of locally active, non-absorbable antibiotics for treatment of SIBO.METHODS: Our survey included 115 patients fulfilling the Rome II criteria for diagnosis of irritable bowel syndrome (IBS); a total of 97 patients accepted to perform a breath test with lactulose (BTLact), and those who had a positive test, received Rifaximin (Normix , Alfa Wassermann) 1200 mg/d for 7 d; 3 wk after the end of treatment, the BTLact was repeated.RESULTS: Based on the BTLact results, SIBO was present in about 56% of IBS patients, and it was responsible for some IBS-related symptoms, such as abdominal bloating and discomfort, and diarrhoea. 1-wk treatment with Rifaximin turned the BTLact to negative in about 50% of patients and significantly reduced the symptoms, especially in those patients with an alternated constipation/diarrhoea-variant IBS. CONCLUSION: SIBO should be always suspected in patients with IBS, and a differential diagnosis is done by means of a "breath test". Rifaximin may represent a valid approach to the treatment of SIBO. 展开更多
关键词 RIFAXIMIN Small intestinal bacterialovergrowth Irritable bowel syndrome Locally nonabsorbable antibiotics
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部